Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Angell

Showing results (121-130 of 164) with videos related to

Pageof 17
Sort By:
Disaster Medicine and Public Health Preparedness|April 23, 2025
Integrating Human and Animal Health in the STOP Spillover Outbreak ScenariosKathleen E Angell, He Julia Bai, Katherine C Prager, et al.
Journal of Public Health Management and Practice : JPHMP|March 3, 2025
Active and Passive Vector Surveillance Systems in Lyme Endemic Minnesota and Their Correlation to Human DiseaseKathleen E Angell, Janet Jarnefeld, Elizabeth K Schiffman, et al.
Thyroid : Official Journal of the American Thyroid Association|January 25, 2017
Noninvasive Follicular Thyroid Neoplasm with Papillary-Like Nuclear Features Accounts for More Than Half of "Carcinomas" Harboring RAS MutationsVera A Paulson, Priyanka Shivdasani, Trevor E Angell, et al.
The Journal of Biological Chemistry|May 2, 2001
Regulation of interferon and retinoic acid-induced cell death activation through thioredoxin reductaseX Ma, S Karra, W Guo, et al.
Annals of Surgical Oncology|October 21, 2018
Effect of Noninvasive Follicular Thyroid Neoplasm with Papillary-Like Nuclear Features (NIFTP) on Malignancy Rates in Thyroid Nodules: How to Counsel Patients on Extent of SurgeryBrenessa M Lindeman, Matthew A Nehs, Trevor E Angell, et al.
Thyroid : Official Journal of the American Thyroid Association|January 13, 2016
Circulating Myeloid-Derived Suppressor Cells Predict Differentiated Thyroid Cancer Diagnosis and ExtentTrevor E Angell, Melissa G Lechner, Alison M Smith, et al.
Cancer Immunology, Immunotherapy : CII|March 11, 2016
Systemic delivery of chTNT-3/CpG immunoconjugates for immunotherapy in murine solid tumor modelsJulie K Jang, Leslie A Khawli, David C Canter, et al.
AACE Clinical Case Reports|December 6, 2016
HIGH-DOSE BIOTIN TREATMENT FOR SECONDARY PROGRESSIVE MULTIPLE SCLEROSIS MAY INTERFERE WITH THYROID ASSAYSAlissa Minkovsky, Mark N Lee, Mitra Dowlatshahi, et al.
Journal of Microscopy|April 29, 2005
Porphyrin-related photosensitizers for cancer imaging and therapeutic applicationsK Berg, P K Selbo, A Weyergang, et al.
Jac-Antimicrobial Resistance|July 5, 2021
Antibacterial use in the age of SARS-CoV-2Kathleen E Angell, James V Lawler, Angela L Hewlett, et al.
Pageof 17

Showing results (121-130 of 164) with videos related to

Sort By:
Pageof 17
Disaster Medicine and Public Health Preparedness|April 23, 2025
Integrating Human and Animal Health in the STOP Spillover Outbreak ScenariosKathleen E Angell, He Julia Bai, Katherine C Prager, et al.
Journal of Public Health Management and Practice : JPHMP|March 3, 2025
Active and Passive Vector Surveillance Systems in Lyme Endemic Minnesota and Their Correlation to Human DiseaseKathleen E Angell, Janet Jarnefeld, Elizabeth K Schiffman, et al.
Thyroid : Official Journal of the American Thyroid Association|January 25, 2017
Noninvasive Follicular Thyroid Neoplasm with Papillary-Like Nuclear Features Accounts for More Than Half of "Carcinomas" Harboring RAS MutationsVera A Paulson, Priyanka Shivdasani, Trevor E Angell, et al.
The Journal of Biological Chemistry|May 2, 2001
Regulation of interferon and retinoic acid-induced cell death activation through thioredoxin reductaseX Ma, S Karra, W Guo, et al.
Annals of Surgical Oncology|October 21, 2018
Effect of Noninvasive Follicular Thyroid Neoplasm with Papillary-Like Nuclear Features (NIFTP) on Malignancy Rates in Thyroid Nodules: How to Counsel Patients on Extent of SurgeryBrenessa M Lindeman, Matthew A Nehs, Trevor E Angell, et al.
Thyroid : Official Journal of the American Thyroid Association|January 13, 2016
Circulating Myeloid-Derived Suppressor Cells Predict Differentiated Thyroid Cancer Diagnosis and ExtentTrevor E Angell, Melissa G Lechner, Alison M Smith, et al.
Cancer Immunology, Immunotherapy : CII|March 11, 2016
Systemic delivery of chTNT-3/CpG immunoconjugates for immunotherapy in murine solid tumor modelsJulie K Jang, Leslie A Khawli, David C Canter, et al.
AACE Clinical Case Reports|December 6, 2016
HIGH-DOSE BIOTIN TREATMENT FOR SECONDARY PROGRESSIVE MULTIPLE SCLEROSIS MAY INTERFERE WITH THYROID ASSAYSAlissa Minkovsky, Mark N Lee, Mitra Dowlatshahi, et al.
Journal of Microscopy|April 29, 2005
Porphyrin-related photosensitizers for cancer imaging and therapeutic applicationsK Berg, P K Selbo, A Weyergang, et al.
Jac-Antimicrobial Resistance|July 5, 2021
Antibacterial use in the age of SARS-CoV-2Kathleen E Angell, James V Lawler, Angela L Hewlett, et al.
Pageof 17